Speaker illustration

Doctor Hayato Tada

Kanazawa University, Kanazawa (Japan)

Member of:

European Society of Cardiology

EXPERIENCES: 2003 - 04 Resident in Medicine, Kanazawa University Hospital, Kanazawa, Japan 2004 - 05 Clinical Fellow in Cardiology and Internal Medicine Kouseiren Takaoka Hospital, Takaoka, Japan 2005 - 06 Clinical Fellow in Fukui Cardiovascular Center, Fukui, Japan 2006 - 10 Medical Staff in Division of Cardiovascular Medicine Kanazawa University Hospital, Kanazawa, Japan 2011 - 12 Assistant Professor Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan 2012 - 14 Research Scholar Massachusetts General Hospital Center for Human Genetic Research, Boston, MA, USA 2014 - Assistant Professor Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan

Early diagnosis and treatments in childhood are associated with better prognosis in patients with familial hypercholesterolemia

Event: ESC Congress 2023

Topic: Lipids

Session: Risk factors and prevention: lipids (5)

Thumbnail

Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia

Event: ESC Congress 2023

Topic: Lipids

Session: Risk factors and prevention: lipids (5)

Thumbnail

Impact of coronary artery calcium on the prognosis of heterozygous familial hypercholesterolemia

Event: ESC Congress 2023

Topic: Lipids

Session: Imaging or biomarkers: which is superior in risk prediction?

Thumbnail

Impact of cumulative exposure to LDL cholesterol on cardiovascular events in patients with familial hypercholesterolemia

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipids

Session: Congress committee e-posters choice in preventive cardiology and special populations

Thumbnail

Achilles tendon thickness assessed by X-ray predicting a pathogenic mutation in familial hypercholesterolemia gene

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipids

Session: Risk Factors and Prevention ePosters

Thumbnail

Prognostic impact of cascade screening for familial hypercholesterolemia on cardiovascular events

Event: ESC Congress 2020

Topic: Lipids

Session: Risk Factors and Prevention ePosters

Thumbnail

Lipoprotein(a) and risk of chronic kidney disease among 4,235 japanese hospitalized patients

Event: ESC Congress 2019

Topic: Lipids

Session: Lipids

Thumbnail

Beneficial effect of ezetimibe-atorvastatin combination therapy in patients with a mutation in ABCG5 or ABCG8 gene

Event: ESC Congress 2019

Topic: Cardiovascular Risk Assessment

Session: Lipids

Thumbnail

Clinical impact of carotid plaque score rather than carotid intima-media thickness on atherosclerotic cardiovascular disease

Event: ESC Congress 2019

Topic: Cardiovascular Risk Assessment

Session: Risk Factors and Prevention, Cardiovascular Disease in Special Populations

Thumbnail

Validation of clinical diagnostic criteria of familial hypercholesterolemia in Japan: evidence from a comprehensive genetic analysis

Event: ESC Congress 2019

Topic: Cardiovascular Risk Assessment

Session: Lipids

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb